SEC Form 4 · accession 0000899243-19-001159
Invitae Corp · NVTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert L Nussbaum
Officer — Chief Medical Officer
Period of report
Jan 10, 2019
Accepted (ET)
Jan 14, 2019 · 9:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501134
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3,F4 | Jan 10, 2019 | S | 5,222 | $14.0087 | D | 163,769 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2018.
- F2Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- F3Represents weighted average sale price. Actual sale prices ranged from $14.00 to $14.05.
- F4Includes an aggregate of 164,235 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.